VJGJ, INC., et. al.

  1. December 14, 2021

    3-Part Ch. 11 Stalking Horse Sale OK'd For Teligent

    Bankrupt generic pharmaceuticals venture Teligent Inc. secured a Delaware judge's approval Tuesday for a three-part stalking horse sale that could net the business $64 million or even more if other offers surface.

  2. October 15, 2021

    Teligent's Distributors Balk At Customer Risks In Ch. 11

    An unexpected lawsuit that emerged earlier this year from Insys Therapeutics Inc.'s bankruptcy case in Delaware raised concerns on Friday among Teligent Inc.'s largest pharmaceutical distributors that the bankrupt generic-drug manufacturer could put their customer programs at risk.

  3. October 14, 2021

    Pharma Co. Teligent Opens Ch. 11 In Del. With $130M Debt

    Generic pharmaceutical company Teligent Inc. sought Chapter 11 protection in Delaware on Thursday with nearly $130 million in debt and plans for a sale, saying it has been dealing with "regulatory headwinds" and the impact of the COVID-19 pandemic.